Kura Oncology, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -25.8% | -25.8% | -24.4% |
| FY2022 | -32.3% | -31.6% | -29.8% |
| FY2023 | -38.4% | -37.5% | -34.0% |
| FY2024 | -42.1% | -41.4% | -22.9% |
| FY2025 | -160.0% | -151.6% | -37.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -25.8% | -25.8% | -24.4% |
| FY2022 | -32.3% | -31.6% | -29.8% |
| FY2023 | -38.4% | -37.5% | -34.0% |
| FY2024 | -42.1% | -41.4% | -22.9% |
| FY2025 | -160.0% | -151.6% | -37.7% |